From working a temp job in the shipping department to organizing teacher training, maintaining an antebellum mansion and learning the ins and outs of professional medical practice, David Haag has had a career in membership societies that has been anything but boring. And as of this March, he finds himself in pursuit of his next…
The ARHP is pleased to announce the relaunch of its highly successful online Fundamentals of Rheumatology Course (FRC). This updated version is earning high marks from users and reviewers for ease of navigation, choice of presentation formats, depth of research and separate learning activities (i.e., modules) for the care of adult and pediatric patients. According…
Effective volunteer leaders inspire their committees, and together, they accomplish ambitious goals to ensure the future of rheumatology. Expert consultants shared tips and tools for effective leadership at this year’s ACR/ARHP Leadership Conference, held Jan. 22 in Atlanta. “We view your role in the ACR as volunteers to be critical, not only for the success…
In 2017, did you interact with the Medicare payment system, receive payment for a consultation code or worry about the Centers for Medicare & Medicaid Services (CMS) reducing reimbursement through its proposed Part B Demonstration Project? If your answer to any of those questions is yes, then you directly benefited from the ACR/ARHP’s advocacy efforts….
SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting in San Diego in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ARHP winners about their individual contributions. In addition, we profile the new class…
Translational research is designed to investigate a particular disease process to achieve an improved outcome for patients. Here are some insights into how to bring together the right people for a research team and keep that team focused…
The ACR Board of Directors approved the ARHP Master Designation at its August 2017 meeting. The first two ARHP Master Designation awardees will be honored at the ACR/ARHP Annual Meeting in Chicago on Oct. 20, 2018. Recognition as a Master of the ARHP is one of the highest honors that the ARHP bestows to members….
Two decades have passed since the first biologic disease-modifying anti-rheumatic drug (bDMARD) was approved. Studies on the long-term use of biologics in different disease states, such as for cardiovascular disease (CVD) and malignancy, as well as for knee/hip replacement, reveal some encouraging news. In clinical trials, bDMARDs have been shown to increase the risk of…
SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting in San Diego last month, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ACR winners about their individual contributions to advancing rheumatology. In coming issues, we…
Sandra Mintz, MSN, RN, knew in high school that she wanted to be a nurse, and upon graduation, she did just that, the youngest in her class to graduate from Pasadena City College with an Associate of Science in nursing. Not long after embarking on her career, she received a life-altering medical diagnosis of her…